REHOVOT, Israel, and BRIDGEWATER, New Jersey, April 26, 2017 /PRNewswire/ — Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs…
April 26, 2017 at 05:48PM
from
No comments:
Post a Comment